# Chongqing Primary Aldosteronism Study

> **NCT03224312** · — · RECRUITING · sponsor: **Chongqing Medical University** · enrollment: 1500 (estimated)

## Conditions studied

- Primary Aldosteronism

## Interventions

- **OTHER:** no intervention

## Key facts

- **NCT ID:** NCT03224312
- **Lead sponsor:** Chongqing Medical University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2016-10-01
- **Primary completion:** 2027-12-31
- **Final completion:** 2028-12-31
- **Target enrollment:** 1500 (ESTIMATED)
- **Last updated:** 2023-09-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03224312

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03224312, "Chongqing Primary Aldosteronism Study". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03224312. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*